The following table reconciles the numerator and denominator used in the computation of earnings per share for the three months ended March 31, 2013 and 2012 (shares in thousands):

	For the Three Months Ended March 31,

	2013			2012
Numerator
Income from continuing operations	$	22,526		$	48,209
Income (loss) from discontinued operations		4			(59,932	)
Net income attributable to noncontrolling interests		(4,438	)		(2,345	)

Net income (loss) attributable to the Company		18,092			(14,068	)
Allocation of earnings to participating securities		(66	)		(317	)

Numerator for basic and diluted earnings per share—net income (loss) attributable to common stockholders	$	18,026		$	(14,385	)

Denominator
Denominator for basic earnings per share—weighted average number of common shares outstanding		137,538			132,273
Effect of dilutive securities:(1)
Share and unit-based compensation plans		78			—

Denominator for diluted earnings per share—weighted average number of common shares outstanding		137,616			132,273

Earnings per common share—basic:
Income from continuing operations	$	0.13		$	0.31
Discontinued operations		—			(0.42	)

Net income (loss) attributable to common stockholders	$	0.13		$	(0.11	)

Earnings per common share—diluted:
Income from continuing operations	$	0.13		$	0.31
Discontinued operations		—			(0.42	)

Net income (loss) attributable to common stockholders	$	0.13		$	(0.11	)

(1)

The convertible senior notes ("Senior Notes") are excluded from diluted EPS for the three months ended March 31, 2012 as their impact was antidilutive. The Senior Notes were paid off in full on March 15, 2012 (See Note 10—Bank and Other Notes Payable).

Diluted EPS excludes 184,304 and 208,640 convertible preferred units for the three months ended March 31, 2013 and 2012, respectively, as their impact was antidilutive.

Diluted EPS excludes 1,156,985 unexercised stock appreciation rights ("SARs") for the three months ended March 31, 2012 as their impact was antidilutive.

Diluted EPS excludes 13,500 unexercised stock options for the three months ended March 31, 2012 as their impact was antidilutive.

Diluted EPS excludes 623,572 unexercised stock warrants for the three months ended March 31, 2012 as their impact was antidilutive. The stock warrants were exercised in full on October 24, 2012.

Diluted EPS excludes 10,206,924 and 11,178,828 Operating Partnership units ("OP Units") for the three months ended March 31, 2013 and 2012, respectively, as their impact was antidilutive.